Market news
Meetings in Shanghai and Changzhou link VitaGuard's commercial use in China with BioNexus' Southeast Asian plans and Fidelion's international licensing efforts Dr. Muthu Meyyappan, Chief Commercial Officer of Fidelion Diagnostics, meets with representatives of Tongshu Gene during working sessions in China focused on VitaGuard™ technology transfer, implementation planning and international commercialization. Dr. Muthu Meyyappan, Chief Commercial Officer of Fidelion Diagnostics, meets with represe
Gainers Eos Energy Enterprises, Inc. - Right (NASDAQ:EOSER) stock increased by 74.7% to $0.05 during Thursday's pre-market session. Decent Holding (NASDAQ:DXST) shares rose 22.11% to $2.54. The market value of
This is the newest page. Registered accounts read further back.